What grade does USPSTF assign to cervical cancer screening for women aged 21 to 65?

What grade does USPSTF assign to cervical cancer screening for women aged 21 to 65?

• A. Grade A
• B. Grade B
• C. Grade C
• D. Grade D

Answer: (A)

High certainty of substantial net benefit from screening cervical cancer in women aged 21 to 65 is why the USPSTF assigns the top grade. This age group benefits significantly from early detection and prevention of cervical cancer, with substantial reductions in incidence and mortality demonstrated in evidence. The recommended approaches—cytology (Pap) every 3 years for 21–29, and either cytology every 3 years or HPV testing (with or without cytology) every 5 years for 30–65—reflect the strong balance of benefits over harms, despite potential issues like false positives or follow-up procedures. In this framework, a Grade A designation signals the highest level of confidence in a substantial net benefit.

High certainty of substantial net benefit from screening cervical cancer in women aged 21 to 65 is why the USPSTF assigns the top grade. This age group benefits significantly from early detection and prevention of cervical cancer, with substantial reductions in incidence and mortality demonstrated in evidence. The recommended approaches—cytology (Pap) every 3 years for 21–29, and either cytology every 3 years or HPV testing (with or without cytology) every 5 years for 30–65—reflect the strong balance of benefits over harms, despite potential issues like false positives or follow-up procedures. In this framework, a Grade A designation signals the highest level of confidence in a substantial net benefit.